Close

Monthly Archives: September, 2017

UPM Raflatac expands offering with new innovations for medical device and healthcare labeling

UPM Raflatac has further expanded its range of guaranteed, globally available, and compliant pharmaceutical and healthcare label materials for the medical device and healthcare...

New University of California Cancer Consortium to tackle state’s second leading cause of death

The University of California’s five academic cancer centers, home to some of the world’s leading scientists and physicians, have formed a consortium to better...

NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award

Two scientists at the National Cancer Institute (NCI) will receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the...

Siemens Healthineers Debuts TrueFusion Application for Treatment of Structural Heart Disease

Siemens Healthineers has introduced TrueFusion1, an application on the new Release 5.0 of the ACUSON SC2000 cardiovascular ultrasound system that integrates ultrasound and angiography...

Endomag Receives CE Mark Approval for Magseed Breast Cancer Localisation Technology

Endomag announced today that it has received CE Mark approval for Magseed®, a minimally invasive breast marker used to accurately guide surgeons during breast...

Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer

The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid (1), showed that adding the cyclin-dependent kinase (CDK) 4/6...

New biomarker predicts metastatic prostate cancers

Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read